Vanta Bioscience Ltd
BSE:540729

Watchlist Manager
Vanta Bioscience Ltd Logo
Vanta Bioscience Ltd
BSE:540729
Watchlist
Price: 19.5 INR Market Closed
Market Cap: ₹138.6m

Operating Margin

-614.2%
Current
Declining
by 393.6%
vs 3-y average of -220.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-614.2%
=
Operating Income
₹-75.8m
/
Revenue
₹12.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-614.2%
=
Operating Income
₹-75.8m
/
Revenue
₹12.3m

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Vanta Bioscience Ltd
BSE:540729
138.7m INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
166B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.2B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
276.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.7B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.4B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.9B EUR
Loading...

Market Distribution

Lower than 97% of companies in India
Percentile
3nd
Based on 5 437 companies
3nd percentile
-614.2%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Vanta Bioscience Ltd
Glance View

Vanta Bioscience Ltd. engages in the full service preclinical contract research organization. The company is headquartered in Secunderabad, Telangana. The company went IPO on 2017-10-06. The firm is engaged in research and development in the field of discovery and development of drugs, biological, vaccines, gene-based therapies, as well as diagnostics and cosmetics, including clinical research. The company provides risk assessment services for evaluating the safety of the active pharmaceutical ingredients (API), excipients, extractable and leachable, including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. The company also provides expert services for determination of health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), including occupational exposure limits (OEL) for pharmaceutical manufacturers. The firm's subsidiaries include Vanta Clinical Research Limited and Vayam Research Solutions Limited.

VANTABIO Intrinsic Value
12.1 INR
Overvaluation 38%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-614.2%
=
Operating Income
₹-75.8m
/
Revenue
₹12.3m
What is Vanta Bioscience Ltd's current Operating Margin?

The current Operating Margin for Vanta Bioscience Ltd is -614.2%, which is below its 3-year median of -220.6%.

How has Operating Margin changed over time?

Over the last 3 years, Vanta Bioscience Ltd’s Operating Margin has decreased from -7.6% to -614.2%. During this period, it reached a low of -614.2% on Oct 30, 2025 and a high of -7.6% on Aug 30, 2022.

Back to Top